Verastem reported $-17709000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
AstraZeneca AZN:LN USD 2.26B 427M
Cytokinetics CYTK:US USD -108441000 97.57M
Gilead Sciences GILD:US USD 2.81B 784M
Immunogen IMGN:US USD -77429000 16.38M
Laboratory Of America LH:US USD 521.6M 48.7M
Novartis NOVN:VX USD 3.33B 8M
Pfizer PFE:US USD 9.7B 2.43B
Tg Therapeutics TGTX:US USD -34963000 3.98M
Verastem VSTM:US USD -17709000 3.69M
YTE INCY:US USD 118.25M 142.04M